Pharmacokinetic analysis across studies to drive knowledge-integration: A tutorial on individual patient data...

Area of Science:

• Pharmacology
• Pharmacometrics
• Drug Development

Background:

• Integrating pharmacokinetic (PK) data across studies is crucial for addressing complex drug development questions.
• Knowledge integration using multiple data sources is gaining traction due to data sharing and advanced computational methods.
• Individual patient data meta-analysis (IPDMA) offers a powerful approach for combining detailed patient-level data.

Purpose of the Study:

• To provide a tutorial on the methodology for conducting individual patient data meta-analysis (IPDMA) in population pharmacokinetic (PK) analysis.
• To highlight key considerations for IPDMA that differ from standard PK modeling.
• To guide pharmacologic modelers in performing integrated PK data analyses across studies.

Main Methods:

• Leveraging systematic reviews of databases and literature for data acquisition.
• Utilizing quantitative modeling of PK processes with individual patient data.
• Incorporating hierarchical nested variability terms to capture interstudy heterogeneity.
• Addressing between-assay differences in quantification limits within a single analysis.

Main Results:

• IPDMA allows for characterization of PK across diverse regions or populations.
• Combining smaller trials via IPDMA can increase statistical power for subpopulations.
• The tutorial outlines specific methodological adaptations for IPDMA in population PK analysis.

Conclusions:

• IPDMA is a valuable method for answering complex questions in drug development that extend beyond individual studies.
• The tutorial provides practical guidance on implementing IPDMA, focusing on interstudy variability and assay differences.
• Pharmacological modelers can use this methodology for systematic and thorough integrated PK data analysis.